A study of peroxisome proliferator-activated receptor (PPAR) alpha in patients with ischemic heart disease and heal thy volunteers

Ischemic heart disease (IHD) is the most common cause of cardiovascular mortality in Malaysia and around the globe. New novel biomarker, Peroxisome Proliferator-Activated Receptors-Alpha (PPAR-a) was investigated in this study to give significant contribution to early detection of IHD. In this st...

Full description

Bibliographic Details
Main Author: Fong Slew, Wai
Format: Monograph
Language:English
Published: Universiti Sains Malaysia 2008
Subjects:
Online Access:http://eprints.usm.my/48977/
http://eprints.usm.my/48977/1/FONG%20SIEW%20WAI%20-%2024%20pages.pdf
_version_ 1848881309076684800
author Fong Slew, Wai
author_facet Fong Slew, Wai
author_sort Fong Slew, Wai
building USM Institutional Repository
collection Online Access
description Ischemic heart disease (IHD) is the most common cause of cardiovascular mortality in Malaysia and around the globe. New novel biomarker, Peroxisome Proliferator-Activated Receptors-Alpha (PPAR-a) was investigated in this study to give significant contribution to early detection of IHD. In this study, we investigated the mRNA expression and protein levels of both PPAR-a and C-Reactive Protein (CRP) genes in the peripheral blood of IHD patients (n=10) and apparently healthy volunteers (n=1 0). The mRNA levels of PPAR-a (native and truncated) and CRP were determined by reverse transcription-polymerase chain reaction. The protein expression was evaluated by Western blot and measured by Enzyme linked immunosorbent assay (ELISA). The CRP mRNA expression and serum levels increased significantly (p<0.05) in IHD patients compared to normal volunteers. There was presence of both native active and truncated inhibitory PPAR-a protein in human blood leukocytes. The mRNA expressions of both native and truncated variants of PPAR-a were lower (p <0.05) in IHD patients group than those in the normal volunteers group. However, there was no significant difference (p>0.05) in PPAR-a protein level between IHD patients and normal volunteers. These findings suggest that mRNA expression level of both PPAR-a variants is decreased in IHD patients. An over-expression of the truncated inhibitory isoform of PPAR-a protein may be involved in the pathogenesis of IHD. Further study will be conducted to elucidate this matter.
first_indexed 2025-11-15T18:16:58Z
format Monograph
id usm-48977
institution Universiti Sains Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T18:16:58Z
publishDate 2008
publisher Universiti Sains Malaysia
recordtype eprints
repository_type Digital Repository
spelling usm-489772021-04-21T08:00:57Z http://eprints.usm.my/48977/ A study of peroxisome proliferator-activated receptor (PPAR) alpha in patients with ischemic heart disease and heal thy volunteers Fong Slew, Wai R Medicine (General) Ischemic heart disease (IHD) is the most common cause of cardiovascular mortality in Malaysia and around the globe. New novel biomarker, Peroxisome Proliferator-Activated Receptors-Alpha (PPAR-a) was investigated in this study to give significant contribution to early detection of IHD. In this study, we investigated the mRNA expression and protein levels of both PPAR-a and C-Reactive Protein (CRP) genes in the peripheral blood of IHD patients (n=10) and apparently healthy volunteers (n=1 0). The mRNA levels of PPAR-a (native and truncated) and CRP were determined by reverse transcription-polymerase chain reaction. The protein expression was evaluated by Western blot and measured by Enzyme linked immunosorbent assay (ELISA). The CRP mRNA expression and serum levels increased significantly (p<0.05) in IHD patients compared to normal volunteers. There was presence of both native active and truncated inhibitory PPAR-a protein in human blood leukocytes. The mRNA expressions of both native and truncated variants of PPAR-a were lower (p <0.05) in IHD patients group than those in the normal volunteers group. However, there was no significant difference (p>0.05) in PPAR-a protein level between IHD patients and normal volunteers. These findings suggest that mRNA expression level of both PPAR-a variants is decreased in IHD patients. An over-expression of the truncated inhibitory isoform of PPAR-a protein may be involved in the pathogenesis of IHD. Further study will be conducted to elucidate this matter. Universiti Sains Malaysia 2008-10 Monograph NonPeerReviewed application/pdf en http://eprints.usm.my/48977/1/FONG%20SIEW%20WAI%20-%2024%20pages.pdf Fong Slew, Wai (2008) A study of peroxisome proliferator-activated receptor (PPAR) alpha in patients with ischemic heart disease and heal thy volunteers. Other. Universiti Sains Malaysia. (Submitted)
spellingShingle R Medicine (General)
Fong Slew, Wai
A study of peroxisome proliferator-activated receptor (PPAR) alpha in patients with ischemic heart disease and heal thy volunteers
title A study of peroxisome proliferator-activated receptor (PPAR) alpha in patients with ischemic heart disease and heal thy volunteers
title_full A study of peroxisome proliferator-activated receptor (PPAR) alpha in patients with ischemic heart disease and heal thy volunteers
title_fullStr A study of peroxisome proliferator-activated receptor (PPAR) alpha in patients with ischemic heart disease and heal thy volunteers
title_full_unstemmed A study of peroxisome proliferator-activated receptor (PPAR) alpha in patients with ischemic heart disease and heal thy volunteers
title_short A study of peroxisome proliferator-activated receptor (PPAR) alpha in patients with ischemic heart disease and heal thy volunteers
title_sort study of peroxisome proliferator-activated receptor (ppar) alpha in patients with ischemic heart disease and heal thy volunteers
topic R Medicine (General)
url http://eprints.usm.my/48977/
http://eprints.usm.my/48977/1/FONG%20SIEW%20WAI%20-%2024%20pages.pdf